An Open Label, Local, Multicenter , Phase IIIb Interventional Study to Assess the Efficacy of Tocilizumab (TCZ) in Combination With Methotrexate (MTX) in Indonesian Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Non-biologic DMARDs.
Phase of Trial: Phase III
Latest Information Update: 16 Jul 2014
At a glance
- Drugs Tocilizumab (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 23 May 2013 Actual end date changed from Oct 2012 to Jul 2012 as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.